Modified human plasma polypeptide or Fc scaffolds and their uses

Details for Australian Patent Application No. 2007292903 (hide)

Owner Ambrx, Inc.

Inventors Krawitz, Denise; Feng, Tian; Putnam, Anna-Maria A. Hays; Sheffer, Joseph; Norman, Thea; Dimarchi, Richard D.; Cho, Ho Sung; Chu, Stephanie

Agent FB Rice

Pub. Number AU-B-2007292903

PCT Pub. Number WO2008/030558

Priority 60/928,485 08.05.07 US; 60/843,215 08.09.06 US

Filing date 7 September 2007

Wipo publication date 13 March 2008

Acceptance publication date 29 March 2012

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/030558 Priority application(s): WO2008/030558

29 March 2012 Application Accepted

  Published as AU-B-2007292903

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007292905-HSV-1 and HSV-2 vaccines and methods of use thereof

2007292902-Compositions and methods for enhancing transport through mucus